Skip to main content
Navigate Up
Sign In
 

Neuromuscular

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: (view all)

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator PRA
18-0996 A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients with Charcot-Marie-Tooth Disease Types 1 and X Fridman, Vera, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
08-0623 Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey Of Patients With Documented Transthyretin (TTR) Mutations Or Wild-Type TTR Amyloidosis Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
04-0567 Use of 3,4-Diaminopyridine, and Investigational new drug, in Lambert-Eaton Syndrome Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
17-1396 Prospective, double-blind, randomized, placebo-controlled phase iii study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (proderm study) Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
17-1132 Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study Wicklund, Matthew, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
18-0787 A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy Wicklund, Matthew, MD Neurology, Research Partners
303-724-4644
Eligibility and Information